These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 32863190)

  • 1. Evaluation of Gleason Grade Group 5 in a Contemporary Prostate Cancer Grading System and Literature Review.
    Kamitani R; Matsumoto K; Kosaka T; Takeda T; Hashiguchi A; Tanaka N; Morita S; Mizuno R; Shinojima T; Asanuma H; Oya M
    Clin Genitourin Cancer; 2021 Feb; 19(1):69-75.e5. PubMed ID: 32863190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Gleason grade and Gleason grade group at positive surgical margins: a systematic review and meta-analysis.
    John A; John H; Catterwell R; Selth LA; Callaghan MO
    BJU Int; 2021 May; 127 Suppl 1():13-22. PubMed ID: 33973331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of prostate cancer patients with locally adverse pathologic features after radical prostatectomy: feasibility of active surveillance for cases with Gleason grade 3 + 4 = 7.
    Shangguan X; Dong B; Wang Y; Xu F; Shao X; Sha J; Zhu Y; Pan J; Xue W
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):123-129. PubMed ID: 27650933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of 2005 Gleason grade modification. Population-based study of biochemical recurrence following radical prostatectomy.
    Thomsen FB; Folkvaljon Y; Brasso K; Loeb S; Robinson D; Egevad L; Stattin P
    J Surg Oncol; 2016 Nov; 114(6):664-670. PubMed ID: 27511833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the 2015 Gleason Grade Groups in a Nationwide Population-based Cohort.
    Loeb S; Folkvaljon Y; Robinson D; Lissbrant IF; Egevad L; Stattin P
    Eur Urol; 2016 Jun; 69(6):1135-41. PubMed ID: 26707871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer.
    Ham WS; Chalfin HJ; Feng Z; Trock BJ; Epstein JI; Cheung C; Humphreys E; Partin AW; Han M
    Eur Urol; 2017 Jun; 71(6):907-912. PubMed ID: 27876305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical Prostatectomy.
    Choy B; Pearce SM; Anderson BB; Shalhav AL; Zagaja G; Eggener SE; Paner GP
    Am J Surg Pathol; 2016 Oct; 40(10):1400-6. PubMed ID: 27379821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weighted Gleason Grade Group (WGGG): A new prostate cancer biopsy reporting system with prognostic potential.
    Waingankar N; Martini A; Griffiths L; Shah P; Paulucci DJ; Kotamarti S; Gul Z; Elmasri M; Yaskiv O; Haines K; Lerner S; Vira M; Kavoussi LR; Tewari AK; Kapoor DA; Olsson CA
    Urol Oncol; 2020 Mar; 38(3):78.e15-78.e21. PubMed ID: 31796374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Gleason score on biochemical recurrence in patients with pT3aN0/Nx prostate cancer with positive surgical margins: a multicenter study from the Prostate Cancer Research Committee.
    Song W; Lee DH; Jeon HG; Jeong BC; Seo SI; Lee HM; Choi HY; Kim JW; Lee S; Byun SS; Jeong CW; Kwak C; Cho JS; Ahn H; Jeon SS
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2393-2400. PubMed ID: 28823006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of high grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence-free survival.
    Turker P; Bas E; Bozkurt S; Günlüsoy B; Sezgin A; Postacı H; Turkeri L
    Urol Oncol; 2013 Jan; 31(1):93-8. PubMed ID: 21316989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of the individual risk of each Gleason pattern, including tertiary Gleason pattern 5, after radical prostatectomy: development of the modified Gleason grade grouping (mGGG) model.
    Taguchi S; Uemura Y; Fujimura T; Morikawa T; Naito A; Kawai T; Suzuki M; Kume H; Fukuhara H
    BMC Cancer; 2020 May; 20(1):371. PubMed ID: 32357849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic role of tertiary Gleason pattern 5 in a contemporary grading system for prostate cancer.
    Jang WS; Yoon CY; Kim MS; Kang DH; Kang YJ; Jeong WS; Abalajon MJ; Ham WS; Choi YD
    Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):93-98. PubMed ID: 27845330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of the presence of tertiary Gleason grade 5 in robot-assisted radical prostatectomy specimens in Japanese patients with clinically localized prostate cancer.
    Kamoda N; Ohori M; Hirasawa Y; Inoue R; Hashimoto T; Satake N; Gondo T; Nakagami Y; Nagao T; Ohno Y
    Jpn J Clin Oncol; 2019 Mar; 49(3):276-280. PubMed ID: 30649377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting factors for progression to castration resistance prostate cancer after biochemical recurrence in patients with clinically localized prostate cancer who underwent radical prostatectomy.
    Hashimoto T; Nakashima J; Kashima T; Yamaguchi Y; Satake N; Nakagami Y; Namiki K; Ohno Y
    Int J Clin Oncol; 2020 Sep; 25(9):1704-1710. PubMed ID: 32500468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Initial Gleason Grade on Outcomes during Active Surveillance for Prostate Cancer.
    Masic S; Cowan JE; Washington SL; Nguyen HG; Shinohara K; Cooperberg MR; Carroll PR
    Eur Urol Oncol; 2018 Oct; 1(5):386-394. PubMed ID: 31158077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic impact of downgrading and upgrading from biopsy to radical prostatectomy among men with Gleason score 7 prostate cancer.
    Jang WS; Koh DH; Kim J; Lee JS; Chung DY; Ham WS; Rha KH; Choi YD
    Prostate; 2019 Dec; 79(16):1805-1810. PubMed ID: 31483062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.
    Mithal P; Howard LE; Aronson WJ; Kane CJ; Cooperberg MR; Terris MK; Amling CL; Freedland SJ
    Int J Urol; 2015 Apr; 22(4):362-6. PubMed ID: 25728968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of pathologically localized high-grade prostate cancer treated with radical prostatectomy.
    Heo JE; Park JS; Lee JS; Kim J; Jang WS; Rha KH; Choi YD; Hong SJ; Ham WS
    Medicine (Baltimore); 2019 Oct; 98(42):e17627. PubMed ID: 31626145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favorable Gleason 3 + 4 Prostate Cancer Shows Comparable Outcomes With Gleason 3 + 3 Prostate Cancer: Implications for the Expansion of Selection Criteria for Active Surveillance.
    Lee H; Lee IJ; Byun SS; Lee SE; Hong SK
    Clin Genitourin Cancer; 2017 Dec; 15(6):e1117-e1122. PubMed ID: 28843377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gleason score 5 + 3 = 8 (grade group 4) prostate cancer-a rare occurrence with contemporary grading.
    Kryvenko ON; Williamson SR; Schwartz LE; Epstein JI
    Hum Pathol; 2020 Mar; 97():40-51. PubMed ID: 31923450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.